Related MCD Starbucks Surges; Multiple Analysts Highlighting Pockets Of Strength Baird Describes Brexit Implications For McDonald's My Blueprint For Trading McDonald's (Seeking Alpha)
On CNBC's Options Action, Dan Nathan spoke about unusually high options activity in McDonald's Corporation (NYSE: MCD).
Options trading volume on Wednesday in McDonald's was three times higher than the average daily options volume. When the stock was trading at $119.50 a trader bought 50,000 contracts of the January 2017 125 call options for $3.15. The breakeven for the trade is at $128.15 or approximately 7 percent higher from the closing price on Wednesday.
Nathan thinks it's a good idea to limit risk with calls because there is a risk of McDonald's trading lower to its breakout level from October 2015.
Posted-In: Dan Nathan Options ActionCNBC Options Markets Media
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Top Industrial Disributor Stocks To Buy For 2016: Novo Nordisk A/S(NVO)
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory for the development of next-generation drug delivery devices; and collaboration and licensing agreement with Ablynx nv to discover and develop novel multi-specific Nanobody drug candidates. The compa ny was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
- [By Charles Carlson, CEO and Portfolio Manager, Horizon Investment Services]
For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).
Top Industrial Disributor Stocks To Buy For 2016: Vera Bradley Inc.(VRA)
Vera Bradley, Inc., through its subsidiary, Vera Bradley Designs, Inc., engages in the design, production, marketing, and retail of functional accessories for women under the ?Vera Bradley? brand. Its products include a range of handbags, accessories, and travel and leisure items. The company sells its products to independent retailers located in the United States, as well as to national retailers and third party e-commerce sites. As of January 29, 2011, Vera Bradley, Inc. sold its products directly through 35 full-price stores, 4 outlet stores, verabradley.com, and an annual outlet sale in Fort Wayne, Indiana. The company was founded in 1982 and is headquartered in Fort Wayne, Indiana.
- [By Ben Levisohn]
Men’s Wearhouse (MW) fell 12.1% to $34.08 after reporting disappointing earnings, while Vera Bradley (VRA) managed to turn a 10% loss at the open into a 3.1% drop at the close as investors tried to digest its earnings report.
- [By Roberto Pedone]
My first earnings short-squeeze play is designer, producer and retailer of functional accessories for women Vera Bradley (VRA), which is set to release numbers Wednesday after the market close. Wall Street analysts, on average, expect Vera Bradley to report revenue of $124.81 million on earnings of 32 cents per share.
Just this morning, Lazard Capital said it expects Vera Bradley’s second quarter results to miss guidance and consensus estimates and reiterates a sell rating on the stock with a $16 price target. The firm also said the company’s third quarter outlook will miss estimates due to sales below plan and promotions above plan.
The current short interest as a percentage of the float Vera Bradley is extremely high at 55.2%. That means that out of the 21.61 million shares in the tradable float, 11.09 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 5.4%, or by about 565,000 shares. If the bears get caught pressing their bets into a bullish quarter, then shares of VRA could easily rip higher post-earnings.
From a technical perspective, VRA is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending badly for the last month and change, with shares falling from its high of $26.33 to its intraday low of $18.67. During that move, shares of PBY have been consistently making lower highs and lower lows, which is bearish technical price action.
If you’re bullish on VRA, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance at $20.09 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 423,263 shares. If that breakout hits, then VRA will set up to re-test or possibly take out its 50-day moving average at $21.79 or its 200-day moving average of $23.
- [By Ben Levisohn]
At first glance, Vera Bradley’s (VRA) earnings report looked great. The retailer reported a profit of 37 cents a share, above analyst forecasts of 32 cents.
But in the what-have-you-done-for-me-lately world of the stock market, that was the past, and the present and future, well they don’t look so hot. For the third quarter, the Vera Bradley, which competes against Coach (COH) and Michael Kors (KORS), among others, now expects sales between$128 million to $130 million, below forecasts for about $147 million, and a profit of 30 cents to 35 cents, below forecasts for a 48-cent profit. In 2014, Vera Bradley expects sales of$535 million to $540 million, below forecasts for $575, while its earnings should come in between$1.47 and $1.52, below expectations of $1.72.And did I mention that its margins are expected to decline too?
Put it all together and you have a recipe for a big drop. Vera Bradley’s shares have plunged 10% to $17.50 in after-hours trading.
- [By Monica Gerson]
Vera Bradley, Inc. (NASDAQ: VRA) is expected to report its quarterly earnings at $0.05 per share on revenue of $106.75 million.
Box Inc (NYSE: BOX) is estimated to post a quarterly loss at $0.24 per share on revenue of $88.65 million.
Top 10 US Stocks To Buy Right Now: Gladstone Land Corporation(LAND)
Gladstone Land Corporation, an externally-managed agricultural real estate investment trust, owns and leases farmland for independent and corporate farming operations in the United States. It owns 46 farms covering an area of 23,000 acres in 7 states across the United States. The company also leases a parcel on its property to an oil company. Gladstone Land Corporation was founded in 1997 and is based in McLean, Virginia.
- [By Cameron Swinehart]
Gladstone Land Corp (LAND) –
A U.S. based farmland investment company that currently offers a plus 9% annual distribution. It owns and leases farmland in Florida, California, Michigan and Oregon with appraised land value of $79 million. The distribution is paid monthly which should attract income investors.
Top Industrial Disributor Stocks To Buy For 2016: BioMarin Pharmaceutical Inc.(BMRN)
BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. The company?s commercial products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used for the treatment of mucopolysaccharidosis (MPS) VI; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), a metabolic disease; Aldurazyme used for the treatment of mucopolysaccharidosis I, a genetic disease; and Firdapse used to treat Lambert Eaton Myasthenic Syndrome, an autoimmune disease. It develops GALNS, an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder; PEG-PAL, an enzyme substitution therapy that is under Phase II clinical trial to treat PKU; BMN-673, a Phase I/II clinical trial product for the treatment of cancer; BMN-701, an enzyme replacement therapy, which is under Phase I/II clinical trials for Pompe disease, a glycogen storage disorder; and BMN-111, a peptide therapeutic that is under Phase I clinical trial for the treatment of achondroplasia. The company sells its Naglazyme, Kuvan, and Firdapse products to specialty pharmacies and end-users, such as hospitals and foreign government agencies, which act as retailers; and Naglazyme products to distributors and pharmaceutical wholesalers. It has a collaboration agreement with Genzyme Corporation for the manufacture of Aldurazyme; and an agreement with Merck Serono S.A. for the further development and commercialization of Kuvan and other products containing 6R-BH4 and PEG-PAL for PKU. BioMarin Pharmaceutical Inc. was founded in 1996 and is headquartered in Novato, California.
- [By Ben Levisohn]
SRPT’s dystrophin argument strongly challenged and largely invalidated by the FDA. Recall, the panelists were very critical of dystrophin data for BioMarin Pharmaceutical (BMRN), and we expect a similar level of scrutiny. The FDA points out two major concerns with Sareptas method of quantifying dystrophin expression: 1) reconciling the low correlation between Western blot vs. immunofluroesscence, and 2) overexaggeration of the data. To the first point, not only was the correlation between the two methods not strong, when considering Western blot as a more relevant and reliable quantitative measurement for dystrophin expression, FDA sees the resulting 0.9% (of normal) after 3.5 years as disappointing. To the latter point, the applicants suggestion of an 11.6-fold increase in de novo dystrophin production assumes a baseline of 0.08% dystrophin level, which is below the instruments detection level of 0.25%.
- [By Monica Gerson]
BioMarin Pharmaceutical (NASDAQ: BMRN) shares moved up 1.48% to $78.64. The volume of BioMarin Pharmaceutical shares traded was 966% higher than normal. BioMarin shares jumped on Roche Holding (OTC: RHHBY) takeover report..
Top Industrial Disributor Stocks To Buy For 2016: Huntington Bancshares Incorporated(HBAN)
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services. The companys Retail and Business Banking segment offers financial products and services, including checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans, and small business loans; and investments, insurance, interest rate risk protection, foreign exchange and treasury management services. Its Commercial Banking segment provides corporate risk management services and institutional sales, trading, and underwriting services; commercial property and casualty, employee benefits, personal lines, life and disability, and specialty lines of insurance; and brokerage and agency services for residential and commercial title insurance, and excess and surplus product lines of insurance. The companys Automobile Fi nance and Commercial Real Estate segment offers financing for the purchase of vehicles; financing the acquisition of new and used vehicle inventory of franchised automotive dealerships; and financing for land, buildings, and other commercial real estate owned or constructed by real estate developers, automobile dealerships, or other customers. Its Regional Banking and The Huntington Private Client Group segment provides deposits, lending, and other banking services; wealth management services, and retirement plan and corporate trust services; brokerage, annuities, advisory, and other investment products. The companys Home Lending segment offers consumer loans and mortgages. The company also offers equipment leasing; and online, mobile, and telephone banking services. Huntington Bancshares Incorporated was founded in 1866 and is headquartered in Columbus, Ohio.
- [By Ben Levisohn]
Who is at the lower-end of the range for 2016 payout ratios? We expect Zions Bancorporation, Huntington Bancshares (HBAN), andBank of America to seek the least amount of capital return in 2016 (ranging between 50-60% of estimated earnings).
Top Industrial Disributor Stocks To Buy For 2016: Palo Alto Networks, Inc.(PANW)
Palo Alto Networks, Inc. provides enterprise security platform to enterprises, service providers, and government entities worldwide. Its platform includes Next-Generation Firewall that delivers application, user, and content visibility and control, as well as protection against network-based cyber threats; Advanced Endpoint Protection that prevents cyber attacks that exploit software vulnerabilities on various fixed and virtual endpoints and servers; and Threat Intelligence Cloud that offers central intelligence capabilities, security for software as a service applications, and automated delivery of preventative measures against cyber attacks. The company provides firewall appliances; Panorama, a centralized security management solution for the control of appliances deployed on an end-customers network as a virtual or a physical appliance; and Virtual System Upgrades, which are available as extensions to the virtual system c apacity that ships with the appliance. It also offers subscription services, such as threat detection and prevention, URL filtering, laptop and mobile devices protection, malware and threats protection, and windows-based fixed and virtual endpoints protection services; support and maintenance services; and professional services, including application traffic management, solution design and planning, configuration, and firewall migration services, as well as provides education services. Palo Alto Networks, Inc. primarily sells its products and services through its channel partners, as well as directly to medium to large enterprises, service providers, and government entities operating in various industries comprising education, energy, financial services, government entities, healthcare, Internet and media, manufacturing, public sector, and telecommunications. The company was founded in 2005 and is headquartered in Santa Clara, California.
- [By Lisa Levin]
Palo Alto Networks Inc (NYSE: PANW) was down, falling around 12 percent to $130.81 as the company issued disappointing forecast for the current quarter. The company also reported in-line earnings for its third quarter, while sales exceeded analysts’ estimates.